IGF2BP3 which bind Lnc-DMDRMR to stabilize the cell-cycle kinase CDK4 in an m6A-dependent manner, ultimately enhancing the G1-S transition and promoting tumour progression in RCC. The gene discussed is IGF2BP3; the disease is neoplasm.